Open access

639 Immune-related thyroid dysfunction in patients with existing thyroid dysfunction
Francois Kaleta, Heather Brody, Praveen Namireddy

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A382-A383; DOI: 10.1136/jitc-2020-SITC2020.0639
638 Plasma proteome analysis in patients with immune checkpoint inhibitors related arthritis and pneumonitis
Noha Abdel-Wahab, Adi Diab, Hiroyuki Katayama, Sang Kim, Samir Hanash, Maria Suarez-Almazor

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A382; DOI: 10.1136/jitc-2020-SITC2020.0638
640 Characterizing severe acute kidney injury in patients treated with immune checkpoint inhibitors
Chung-Jiah Chen, Lisa Kim, Ashley Weaver, Sandip Patel

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A383-A384; DOI: 10.1136/jitc-2020-SITC2020.0640
643 Autopsy review of chimeric-antigen receptor T cell therapy: a single institution experience
KiBeom Kwon, David Woolston, Alexandre Hirayama, Damian Green, David Maloney, Cameron Turtle, Cecilia Yeung

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A386; DOI: 10.1136/jitc-2020-SITC2020.0643
62 Identify immune cell types and biomarkers associated with immune-related adverse events using single cell RNA sequencing
Jiamin Chen, Lance Pflieger, Sue Grimes, Tyler Baker, Michael Brems, Gail Fulde, Shawnee Snow, Parker Howe, Anuja Sathe, Bryce Christensen, Hanlee Ji, Terence Rhodes

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A39; DOI: 10.1136/jitc-2020-SITC2020.0062
7 Prognostic factors for overall survival in patients with advanced melanoma treated with Anti-PD-1 therapy – the melimmune score
Soraia Lobo-Martins, Diogo Martins-Branco, Patrícia Miguel Semedo, Cecília Melo Alvim, Ana Maria Monteiro, Inês Vendrell, Emanuel Gouveia, Maria José Passos, Luís Costa, André Mansinho, Rita Teixeira de Sousa

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A4; DOI: 10.1136/jitc-2020-SITC2020.0007
668 A toolkit for the quantitative analysis of the spatial distribution of cells of the tumor immune microenvironment
Anna Trigos, Tianpei Yang, Yuzhou Feng, Volkan Ozcoban, Maria Doyle, Anu Pasam, Nikolce Kocovski, Angela Pizzolla, Yu-Kuan Huang, Greg Bass, Simon Keam, Terrence Speed, Paul Neeson, Shahneen Sandhu, David Goode

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A400-A401; DOI: 10.1136/jitc-2020-SITC2020.0668
382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study
Filip Janku, Apostolia Tsimberidou, Veronica Holley, Abha Adat, Ozgur Karakuzu, Greg Call, Gabriele Urschel, Diane Healey, Vincent O’Neill

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A407; DOI: 10.1136/jitc-2020-SITC2020.0382
682 Antibody-mediated blockade of interleukin-10 receptor-alpha promotes the activation of immune cells from in vitro dissociated tumor samples
Alexey Berezhnoy, Kalpana Shah, Daorong Liu, Peter Lung, Vatana Long, Kurt Stahl, Douglas Smith, Francine Chen, Hua Li, Jonathan Li, Ralph Alderson, Valentina Ciccarone, James Tamura, Ezio Bonvini, Gundo Diedrich, Paul Moore

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A409-A410; DOI: 10.1136/jitc-2020-SITC2020.0682
684 A low affinity bivalent mesothelin-binding MATCH4 multispecific T cell engager increases cytotoxic selectivity for high mesothelin expressing cells
Bithi Chatterjee, Alexandre Simonin, Daniel Snell, Tea Gunde, Christian Hess, Matthias Brock, Stefan Warmuth, Christopher Weinert, Niels Kirk, Dania Diem, Naomi Flückiger, Robin Heiz, Benjamin Küttner, Dana Mahler, Diego Morenzoni, Sandro Wagen, Julia Zeberer, David Urech

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A410-A411; DOI: 10.1136/jitc-2020-SITC2020.0684

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages